Escolar Documentos
Profissional Documentos
Cultura Documentos
PVR
Performance Highlights
Quarterly Performance (Consolidated)
(` cr) Net Sales EBITDA OPM (%) PAT 4QFY13 242 14 5.8 13 4QFY12 117 4 3.6 2 % yoy 106.6 238.3 227bp 499.5 3QFY13 202 34 16.7 9 % qoq 19.9 (58.2) (1,091)bp 45.0
NEUTRAL
CMP Target Price
Investment Period
Stock Info Sector Market Cap (` cr) Net Debt (` cr) Beta 52 Week High / Low Avg. Daily Volume Face Value (`) BSE Sensex Nifty Reuters Code Bloomberg Code Media 1,339 527 0.8 375/147 51,745 10 19,760 5,986 PVRL.BO PVRL@IN
`338 -
PVRs top-line performance was below our estimates, coming in at `242cr. With fourth quarter being a traditionally weak quarter due to prevalence of the examination season, the companys operating performance was weak with OPM coming in at 5.8% and the same resulting in a loss at the PBT level. However, the net profit stood at `13cr, on account of tax write-back (related to entertainment tax). Cinemax financials have been consolidated in the fourth quarter and hence, the numbers are not comparable. Footfalls flat; however, ATP rises: PVR reported a flat yoy growth in footfalls to 5.5mn for comparable properties. However, the average ticket price (ATP) recorded a healthy growth of 13% yoy to `175. Consequently, ticket sales grew by 9% yoy to `73cr. In case of Cinemax, ticket sales grew by 14% to `50cr for comparable properties on back of 20% yoy growth in footfalls and 4% yoy growth in ATP. Strong organic expansion set to continue: The acquisition of Cinemax and robust organic expansion (added 59 screens in FY2013) has made PVR the largest multiplex operator in India with more than 350 screens. The robust organic expansion is set to continue with the company planning to add ~90 screens over FY2014. Outlook and valuation: PVR is expected to register robust revenues on incremental earnings from its newly opened properties, Cinemax acquisition and an impressive movie pipeline. At the CMP of `338, the stock is trading at 15.7x FY2015E EPS. We believe the stock is fairly valued and offers limited upside from the CMP. Hence, we maintain a Neutral view on the stock. Key financials (Consolidated)
Y/E March (` cr) Net sales % chg Net profit (Adj.) % chg EBITDA margin (%) EPS (`) P/E (x) P/BV (x) RoE (%) RoCE (%) EV/Sales (x) EV/EBITDA (x)
Source: Company, Angel Research
Shareholding Pattern (%) Promoters MF / Banks / Indian Fls FII / NRIs / OCBs Indian Public / Others 31.0 25.2 11.8 31.9
3m 4.8
1yr 21.1
3yr 16.6
FY2012
FY2013
FY2014E
FY2015E
521 13.4 27 236.2 15.2 9.7 34.9 3.1 8.0 7.9 1.8 13.0
810 55.4 46 67.3 15.0 11.3 30.0 2.1 9.6 7.2 1.6 11.9
1,359 67.9 68 48.7 17.3 17.2 19.6 2.0 10.3 12.4 0.9 6.2
1,540 13.3 85 25.0 17.4 21.5 15.7 1.8 12.0 14.2 0.8 5.4
Amit Patil 022-39357800 Ext: 6839 amit.patil@angelbroking.com
4QFY13 242 60 24.7 4 1.8 16 6.7 27 11.1 49 20.1 72 29.7 228 14 5.8 17 17 4 (17) (1) (18) (7.3) (29) 165.5 13 0 12 4.9 4 3.0
4QFY12 117 28 23.8 3 2.5 8 7.0 13 11.5 27 23.4 33 28.2 113 4 3.6 5 8 2 (6) (14) (21) (17.5) (8) 40.1 2 (1) (13) (11.3) 3 (3.3)
% yoy 106.6 114.7 45.2 96.2 100.1 77.8 117.4 101.7 238.3 272.3 122.0 86.8 (13.6) 256.8 499.5
3QFY13 202 52 25.8 3 1.7 14 6.8 19 9.3 30 15.0 50 24.7 168 34 16.7 9 12 2 14 0 14 7.2 6 38.5 9 0 9 4.5 3 3.2
% qoq 19.9 15.2 18.1 43.5 61.2 43.9 35.6 (58.2) 89.6 48.4 164.6
FY2013 805 200 24.9 21 2.6 55 6.8 80 9.9 130 16.1 203 25.2 688 117 14.5 37 56 9 33 (1)
FY2012 518 125 24.2 15 2.8 34 6.6 56 10.9 81 15.7 130 25.2 442 76 14.7 18 36 12 33 (2) 31 6.0 6 18.4 28 0 25 4.9 3 9.8
% chg 55.5 60.1 44.7 61.5 41.5 59.5 55.5 55.9 53.2 98.9 53.6 (24.7) (0.6) 3.0 -
75.1
(5.0)
11.2
14.5
200
(` cr)
45
2 15 1
37
80
60
150
100
50 -
40
117 139 117 169 202 242
138 189
88
20 -
4Q11
1Q12
3Q12
4Q12
1Q13
3Q13
Top-line (LHS)
Source: Company, Angel Research, Note: Cinemax financials consolidated from Q4FY2013
35
30 25
( ` cr)
19.4
17.1
20.2 16.3
20.0
19.0
14
4Q13
2Q12
2Q13
13 9 9
(%)
15.0
10.0
20 15
( ` cr)
10
20 28 23
17
3.6
2 (2)
36
34
14
34
5.0 -
1Q12
2Q12
3Q12
4Q12
2Q13
3Q13
4Q13
4Q11
1Q13
4Q11
1Q12
3Q12
1Q13
2Q13
3Q13
EBITDA (LHS)
OPM (RHS)
4Q13
2Q12
4Q12
(%)
33
4QFY13
4QFY12
% yoy
3QFY12
% qoq
214.7 17.9 13.8 (2.0) 244.4 (4.8) 0.4 (0.8) 4.2 (1.0) 15.7 1.3 (17.9)
106.3 7.2 6.8 (0.1) 120.2 (4.8) 1.7 0.5 (0.6) (3.2) 2.9 14.5 (20.6)
187.4 7.2 10.0 (2.2) 202.4 26.9 0.0 (0.6) (3.7) 22.6
442.4
94.2
Footfalls (Mn) Average Ticket Price, ATP (`) F&B Spend Per Head, SPH (`)
Source: Company, Angel Research
(0) 13 12
(20) (3) 4
Investment rationale
Cinemax acquisition to enhance scale and reach
The acquisition of Cinemax has made PVR the biggest player in the multiplex business with 350 plus screens. PVR already had a strong presence in the NCR region with ~94 screens (almost half of the total multiplex screens in NCR region). Post the acquisition, PVR has now established a strong presence in the Mumbai region (which contributes 15% to the box-office) with ~92 screens. Although the deal has resulted in a significant increase in companys debt, thereby increasing the interest cost, the company is expected to benefit from the sheer scale and reach of the combined entity. Set for expansion: PVR added 59 screens in FY2013. The robust organic expansion is set to continue with the company planning to add ~50 screens in 1HFY2014 and another 100 screens over the next 18 months taking the total tally to 500 screens. PVR is expected to register robust revenues on incremental earnings from its newly opened properties, its recent foray into retail entertainment through PVR Blu-O, and an impressive movie pipeline.
Share Price ( `)
Feb-12 Dec-10 Dec-11 Aug-10 Aug-11 Aug-12 Dec-12 Feb-13
Feb-11
270 220
170 120
70
Jun-10 Jun-11 Apr-10 Apr-11
Jun-12
Oct-10
Oct-11
Oct-12
Apr-13
Apr-12
Jun-11
Aug-11
Jun-12
20
Apr-11 Oct-10 Feb-11
Dec-10
Aug-12
Apr-12
Oct-12
Oct-11
Feb-12
Dec-11
Company Background
PVR is one of India's leading multiplex cinema operators. The company is the pioneer of the multiplex culture in the country, as it was the first to establish a multiplex cinema in India, PVR Anupam, in Saket, Delhi, in 1997. The company is also present in the entertainment space through PVR Blu-O bowling alleys.
Dec-12
Feb-13
Apr-13
FY2010 FY2011 FY2012 FY2013 FY2014E FY2015E 334 334 334 (5.1) 300 119 32 42 107 34 (27.5) 10.2 27 7 (43.0) 2.0 16 10 1,395.3 1 0.0 1 (0) (14.6) 1 (0.5) 1 1 (84.5) 0.4 0.5 0.5 (85.8) 459 459 459 37.5 371 156 49 47 118 89 159.0 19.3 67 21 213.0 4.6 16 11 67.8 16 0.0 16 15 98.0 0 (7.9) 8 8 503.9 1.8 3.0 3.0 469.9 521 521 521 13.4 442 175 52 56 159 79 (10.8) 15.2 36 43 100.8 8.2 18 9 29.0 31 95.4 2.4 31 6 18.6 25 0.1 25 25 204.0 4.8 9.7 9.7 222.0 810 810 810 55.4 688 276 84 80 248 121 53.5 15.0 56 65 53.4 8.1 37 5 14.7 32 4.7 1.3 32 (12) (38.5) 44 0.20 44 44 78.3 5.5 11.3 11.3 16.4 1,359 1,359 1,359 67.9 1,124 453 150 150 372 235 93.9 17.3 67 168 156.9 12.4 79 8 7.9 96 199.7 0.0 96 28 29.0 68 68 68 54.3 5.0 17.2 17.2 52.9 1,540 1,540 1,540 13.3 1,272 517 169 169 416 268 14.0 17.4 70 199 18.2 12.9 84 8 6.2 122 26.7 0.0 122 37 30.0 85 85 85 25.0 5.5 21.5 21.5 25.0
(93.6) 2,140.7
Note: Some of the figures from FY2011 onwards are reclassified; hence not comparable with
Total Liabilities
APPLICATION OF FUNDS Net Block (incl CWIP) Investments Current Assets Cash Loans & Advances Other Current liabilities Net Current Assets Mis. Exp. not written off
Total Assets
previous year numbers
Note: Some of the figures from FY2011 onwards are reclassified; hence not comparable with
FY2010 FY2011 FY2012 FY2013E FY2014E FY2015E 1 27 (7) 11 (0) (3) 29 (85) 8 (77) 41 33 3 11 60 12 8 21 16 67 (24) 11 15 (11) 44 (61) 89 28 20 (18) 3 11 (13) 58 21 79 31 36 (1) 14 6 (24) 50 14 17 31 (134) 12 5 14 (140) (58) 79 21 33 56 (6) 32 (12) 7 135 (855) (37) (893) 385.22 428 7 32 774 16 21 37 96 67 (3) 75 28 (50) 157 (119) 30 (89) 0 7 75 (82) (13) 37 24 122 70 (9) 80 37 (27) 199 (113) 7 (106) 0 7 80 (86) 7 24 30
Note: Some of the figures from FY2011 onwards are reclassified; hence not comparable with
Key ratios
Y/E March Valuation Ratio (x) P/E (on FDEPS) P/CEPS P/BV Dividend yield (%) EV/Sales EV/EBITDA EV / Total Assets Per Share Data (`) EPS (Basic) EPS (fully diluted) Cash EPS DPS Book Value Dupont Analysis EBIT margin Tax retention ratio Asset turnover (x) ROIC (Post-tax) Cost of Debt (Post Tax) Leverage (x) Operating ROE Returns (%) ROCE (Pre-tax) Angel ROIC (Pre-tax) ROE Turnover ratios (x) Asset Turnover (Gross Block) Inventory / Sales (days) Receivables (days) Payables (days) WC cycle (ex-cash) (days) Solvency ratios (x) Net debt to equity Net debt to EBITDA Int. Coverage (EBIT / Int.)
previous year numbers
FY2010 FY2011 FY2012 FY2013E FY2014E FY2015E 640.5 30.1 2.8 0.3 2.8 30.2 1.8 0.5 0.5 11.2 1.0 120.6 2.0 1.1 0.9 2.1 0.1 0.1 2.3 1.3 1.5 0.5 0.9 4 16 59 57 0.2 1.5 0.4 112.4 12.1 2.7 0.3 1.9 10.8 1.6 3.0 3.0 27.8 1.1 125.7 4.6 0.0 1.2 0.1 0.1 0.2 0.1 3.7 4.2 2.5 1.2 4 22 44 121 0.2 0.9 1.3 34.9 14.2 3.1 0.4 1.8 13.0 2.1 9.7 9.7 23.8 1.5 109.9 8.2 0.8 1.3 8.6 0.1 0.4 11.8 7.9 9.2 8.0 1.3 4 18 75 61 0.5 1.9 2.3 30.0 13.3 2.1 0.4 1.6 11.9 1.1 11.3 11.3 25.4 1.5 162.2 8.1 1.4 1.5 16.7 0.1 0.7 28.4 7.2 5.1 9.6 1.2 4 17 97 35 0.9 4.7 1.8 19.6 9.9 2.0 0.4 0.9 6.2 1.1 17.2 17.2 34.3 1.5 172.7 12.4 0.7 1.9 16.4 0.1 0.9 30.4 12.4 12.5 10.3 1.8 4 18 65 26 0.8 2.5 2.1 15.7 8.6 1.8 0.4 0.8 5.4 1.0 21.5 21.5 39.2 1.5 187.4 12.9 0.7 1.9 17.2 0.1 0.8 31.0 14.2 14.2 12.0 1.8 4 18 61 28 0.8 2.1 2.4
Note: Some of the figures from FY2011 onwards are reclassified; hence not comparable with
E-mail: research@angelbroking.com
Website: www.angelbroking.com
DISCLAIMER
This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Angel Broking Limited, its affiliates, directors, its proprietary trading and investment businesses may, from time to time, make investment decisions that are inconsistent with or contradictory to the recommendations expressed herein. The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Limited endeavours to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Angel Broking Limited and its affiliates may seek to provide or have engaged in providing corporate finance, investment banking or other advisory services in a merger or specific transaction to the companies referred to in this report, as on the date of this report or in the past. Neither Angel Broking Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Note: Please refer to the important `Stock Holding Disclosure' report on the Angel website (Research Section). Also, please refer to the latest update on respective stocks for the disclosure status in respect of those stocks. Angel Broking Limited and its affiliates may have investment positions in the stocks recommended in this report.
Disclosure of Interest Statement 1. Analyst ownership of the stock 2. Angel and its Group companies ownership of the stock 3. Angel and its Group companies' Directors ownership of the stock 4. Broking relationship with company covered
PVR No No No No
Note: We have not considered any Exposure below ` 1 lakh for Angel, its Group companies and Directors
Ratings (Returns):
10